UCONN Health CenterFarmington, CT
Disclosures:
3322 - Analysis of Theranostic 177Lu-PSMA-617 Therapy Efficacy and Toxicity in Patients with Advanced Prostate Cancer
Tuesday, October 1, 20242:30 PM – 3:45 PM ET